Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002498780 | SCV002776981 | uncertain significance | Finnish congenital nephrotic syndrome | 2022-01-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002515049 | SCV003521984 | likely benign | not provided | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002516361 | SCV003709858 | likely benign | Inborn genetic diseases | 2022-05-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Blueprint Genetics | RCV000157401 | SCV000207140 | uncertain significance | Proteinuria | 2014-09-15 | no assertion criteria provided | clinical testing |